Jasper Therapeutics, Inc. ownership tables show Soleus-related entities collectively report beneficial ownership of up to 276,312 shares, representing 1.0% of common stock. The filing ties the percentage to 27,996,819 shares outstanding as of March 25, 2026.
The report lists holdings by multiple Soleus entities and Guy Levy and includes standard disclaimers that the entities disclaim beneficial ownership except for Section 13(d) purposes.
Positive
None.
Negative
None.
Key Figures
Shares outstanding:27,996,819 sharesCombined Soleus holdings:276,312 sharesReported ownership percent:1.0%+2 more
5 metrics
Shares outstanding27,996,819 sharesas of March 25, 2026 (Form 10-K cover)
Combined Soleus holdings276,312 sharesaggregate reported for Soleus Capital Management, L.P. and related entities
Reported ownership percent1.0%percent of common stock calculated using 27,996,819 shares outstanding
Master Fund holdings (example)118,912 sharesSoleus Capital Master Fund, L.P. reported shared power
Soleus PE holdings (example)157,400 sharesSoleus Private Equity Fund III, L.P. reported shared power
Key Terms
Section 13(d), beneficial ownership, shared dispositive power, Form 10-K cover
4 terms
Section 13(d)regulatory
"disclaims beneficial ownership other than for the purpose of determining their obligations under Section 13(d)"
beneficial ownershipfinancial
"Each of ... disclaims beneficial ownership of these shares held by Master Fund"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
What stake does Soleus hold in Jasper Therapeutics (JSPR)?
Soleus-affiliated entities report ownership of 276,312 shares, or 1.0%. The percentage is calculated using 27,996,819 shares outstanding as of March 25, 2026 from the company's Form 10-K cover page.
Which Soleus entities are listed on the Schedule 13G/A for JSPR?
Entities listed include Soleus Private Equity Fund III, Soleus Capital Master Fund, Soleus Capital Management, Soleus GP, and related LLCs, plus Guy Levy. Each entry shows shared voting and dispositive power amounts tied to specific pools of shares.
Does Guy Levy personally beneficially own the reported shares?
The filing shows Guy Levy with shared voting and dispositive power over 276,312 shares (1.0%). Footnotes state the parties disclaim beneficial ownership except for Section 13(d) purposes, which is a standard legal attribution statement.
What date and share count were used to calculate the percentage ownership?
The percentage is calculated using 27,996,819 shares outstanding as of March 25, 2026. That figure is cited from the cover of the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025.
Are the Soleus holdings reported as sole or shared voting power?
The filing reports shared voting and dispositive power for the listed Soleus entities (for example, 276,312 shared for Soleus Capital Management and Guy Levy). Sole power entries are shown as zero in the table.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 4)
JASPER THERAPEUTICS, INC.
(Name of Issuer)
Common Stock, par value $0.0001 per share
(Title of Class of Securities)
471871202
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
471871202
1
Names of Reporting Persons
Soleus Capital Master Fund, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
118,912.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
118,912.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
118,912.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.4 %
12
Type of Reporting Person (See Instructions)
FI
Comment for Type of Reporting Person: (1) The shares reported in this table are held directly by Master Fund. Soleus Capital, LLC is the sole general partner of Master Fund, Soleus Capital Group, LLC ("SCG") is the sole managing member of Soleus Capital, LLC, SCM is the investment manager for Soleus PE and for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, LLC, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The percentage listed in this table is calculated based upon 27,996,819 shares of common stock of the Issuer outstanding as of March 25, 2026, as set forth on the cover of the Form 10-K
SCHEDULE 13G
CUSIP Number(s):
471871202
1
Names of Reporting Persons
Soleus Private Equity Fund III, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
157,400.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
157,400.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
157,400.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.6 %
12
Type of Reporting Person (See Instructions)
PN
Comment for Type of Reporting Person: (1) The shares reported in this table are held directly by Soleus Private Equity Fund III, L.P. ("Soleus PE"). Soleus Private Equity GP III, LLC ("Soleus PE GP") is the sole general partner of Soleus PE, Soleus PE GP III, LLC is the sole manager of Soleus PE GP, Soleus Capital Management, L.P. ("SCM ") is the investment manager for Soleus PE and for Soleus Capital Master Fund, L.P. ("Master Fund"), and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP III, LLC and of Soleus GP, LLC. Each of Mr. Levy, Soleus PE GP III, LLC, Soleus PE GP, SCM and Soleus GP, LLC disclaims beneficial ownership of these shares held by Soleus PE other than for the purpose of determining their obligations under Section 13(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The percentage listed in this table is calculated based upon 27,996,819 shares of the common stock of Jasper Therapeutics, Inc. (the "Issuer") outstanding as of March 25, 2026, as set forth on the cover of the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025 that was filed with the Securities and Exchange Commission on March 30, 2026 (the "Form 10-K").
SCHEDULE 13G
CUSIP Number(s):
471871202
1
Names of Reporting Persons
Soleus Private Equity GP III, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
157,400.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
157,400.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
157,400.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.6 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: (1) The shares reported in this table are held directly by Soleus PE. Soleus PE GP is the sole general partner of Soleus PE, Soleus PE GP III, LLC is the sole manager of Soleus PE GP, SCM is the investment manager for Soleus PE and for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP III, LLC and of Soleus GP, LLC. Each of Mr. Levy, Soleus PE GP III, LLC, Soleus PE GP, SCM and Soleus GP, LLC disclaims beneficial ownership of these shares held by Soleus PE other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The percentage listed in this table is calculated based upon 27,996,819 shares of common stock of the Issuer outstanding as of March 25, 2026, as set forth on the cover of the Form 10-K.
SCHEDULE 13G
CUSIP Number(s):
471871202
1
Names of Reporting Persons
Soleus PE GP III, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
157,400.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
157,400.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
157,400.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.6 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: (1) The shares reported in this table are held directly by Soleus PE. Soleus PE GP is the sole general partner of Soleus PE, Soleus PE GP III, LLC is the sole manager of Soleus PE GP, SCM is the investment manager for Soleus PE and for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP III, LLC and of Soleus GP, LLC. Each of Mr. Levy, Soleus PE GP III, LLC, Soleus PE GP, SCM and Soleus GP, LLC disclaims beneficial ownership of these shares held by Soleus PE other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The percentage listed in this table is calculated based upon 27,996,819 shares of common stock of the Issuer outstanding as of March 25, 2026, as set forth on the cover of the Form 10-K.
SCHEDULE 13G
CUSIP Number(s):
471871202
1
Names of Reporting Persons
Soleus Capital, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
118,912.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
118,912.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
118,912.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.4 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: (1) The shares reported in this table are held directly by Master Fund. Soleus Capital, LLC is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, LLC, SCM is the investment manager for Soleus PE and for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, LLC, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The percentage listed in this table is calculated based upon 27,996,819 shares of common stock of the Issuer outstanding as of March 25, 2026, as set forth on the cover of the Form 10-K.
SCHEDULE 13G
CUSIP Number(s):
471871202
1
Names of Reporting Persons
Soleus Capital Group, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
118,912.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
118,912.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
118,912.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.4 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: (1) The shares reported in this table are held directly by Master Fund. Soleus Capital, LLC is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, LLC, SCM is the investment manager for Soleus PE and for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, LLC, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The percentage listed in this table is calculated based upon 27,996,819 shares of common stock of the Issuer outstanding as of March 25, 2026, as set forth on the cover of the Form 10-K.
SCHEDULE 13G
CUSIP Number(s):
471871202
1
Names of Reporting Persons
Soleus Capital Management, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
276,312.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
276,312.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
276,312.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
1.0 %
12
Type of Reporting Person (See Instructions)
PN
Comment for Type of Reporting Person: (1) The shares reported in this table are held directly by Soleus PE and by Master Fund. Soleus PE GP is the sole general partner of Soleus PE, Soleus PE GP III, LLC is the sole manager of Soleus PE GP, SCM is the investment manager for Soleus PE, and Soleus GP, LLC is the sole general partner of SCM. Soleus Capital, LLC is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, LLC, SCM is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP III, LLC, SCG and Soleus GP, LLC. Each of Soleus PE GP, Soleus PE GP III, LLC, Soleus Capital, LLC, SCG, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held directly by Soleus PE and Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The percentage listed in this table is calculated based upon 27,996,819 shares of common stock of the Issuer outstanding as of March 25, 2026, as set forth on the cover of the Form 10-K.
SCHEDULE 13G
CUSIP Number(s):
471871202
1
Names of Reporting Persons
Soleus GP, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
276,312.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
276,312.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
276,312.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
1.0 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: (1) The shares reported in this table are held directly by Soleus PE and by Master Fund. Soleus PE GP is the sole general partner of Soleus PE, Soleus PE GP III, LLC is the sole manager of Soleus PE GP, SCM is the investment manager for Soleus PE, and Soleus GP, LLC is the sole general partner of SCM. Soleus Capital, LLC is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, LLC, SCM is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP III, LLC, SCG and Soleus GP, LLC. Each of Soleus PE GP, Soleus PE GP III, LLC, Soleus Capital, LLC, SCG, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held directly by Soleus PE and Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The percentage listed in this table is calculated based upon 27,996,819 shares of common stock of the Issuer outstanding as of March 25, 2026, as set forth on the cover of the Form 10-K.
SCHEDULE 13G
CUSIP Number(s):
471871202
1
Names of Reporting Persons
Guy Levy
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
276,312.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
276,312.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
276,312.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
1.0 %
12
Type of Reporting Person (See Instructions)
IN
Comment for Type of Reporting Person: (1) The shares reported in this table are held directly by Soleus PE and by Master Fund. Soleus PE GP is the sole general partner of Soleus PE, Soleus PE GP III, LLC is the sole manager of Soleus PE GP, SCM is the investment manager for Soleus PE, and Soleus GP, LLC is the sole general partner of SCM. Soleus Capital, LLC is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, LLC, SCM is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP III, LLC, SCG and Soleus GP, LLC. Each of Soleus PE GP, Soleus PE GP III, LLC, Soleus Capital, LLC, SCG, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held directly by Soleus PE and Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The percentage listed in this table is calculated based upon 27,996,819 shares of common stock of the Issuer outstanding as of March 25, 2026, as set forth on the cover of the Form 10-K.
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
JASPER THERAPEUTICS, INC.
(b)
Address of issuer's principal executive offices:
2200 Bridge Parkway, Suite #102 Redwood City, CA 94065
Item 2.
(a)
Name of person filing:
Soleus Private Equity GP III, LLC
Soleus Private Equity Fund III, L.P.
Soleus PE GP III, LLC
Soleus Capital Master Fund, L.P.
Soleus Capital, LLC
Soleus Capital Group, LLC
Soleus Capital Management, L.P.
Soleus GP, LLC
Guy Levy
(b)
Address or principal business office or, if none, residence:
Soleus Private Equity GP III, LLC, 100 Field Point Road, Suite 200, Greenwich, CT 06830
Soleus Private Equity Fund III, L.P., 100 Field Point Road, Suite 200, Greenwich, CT 06830
Soleus PE GP III, LLC, 100 Field Point Road, Suite 200, Greenwich, CT 06830
Soleus Capital Master Fund, L.P., 100 Field Point Road, Suite 200, Greenwich, CT 06830
Soleus Capital, LLC, 100 Field Point Road, Suite 200, Greenwich, CT 06830
Soleus Capital Group, LLC, 100 Field Point Road, Suite 200, Greenwich, CT 06830
Soleus Capital Management, L.P., 100 Field Point Road, Suite 200, Greenwich, CT 06830
Soleus GP, LLC, 100 Field Point Road, Suite 200, Greenwich, CT 06830
Guy Levy c/o Soleus Capital Management, L.P., 100 Field Point Road, Suite 200,
Greenwich, CT 06830
(c)
Citizenship:
Soleus Private Equity GP III, LLC - Delaware
Soleus Private Equity Fund III, L.P. - Delaware
Soleus PE GP III, LLC - Delaware
Soleus Capital Master Fund, L.P. - Cayman Islands
Soleus Capital, LLC - Delaware
Soleus Capital Group, LLC - Delaware
Soleus Capital Management, L.P. - Delaware
Soleus GP, LLC - Delaware
Guy Levy - United States
(d)
Title of class of securities:
Common Stock, par value $0.0001 per share
(e)
CUSIP No.:
471871202
Item 4.
Ownership
(a)
Amount beneficially owned:
The information in rows 5 through 9 and 11 on the cover pages to this Schedule 13G, including the footnotes thereto, is hereby incorporated by reference.
Soleus Private Equity GP III, LLC - 157,400
Soleus Private Equity Fund III, L.P. - 157,400
Soleus PE GP III, LLC - 157,400
Soleus Capital Master Fund, L.P. - 118,912
Soleus Capital, LLC - 118,912
Soleus Capital Group, LLC - 118,912
Soleus Capital Management, L.P. - 276,312
Soleus GP, LLC - 276,312
Guy Levy - 276,312
(b)
Percent of class:
Soleus Private Equity GP III, LLC - 0.6%
Soleus Private Equity Fund III, L.P. - 0.6%
Soleus PE GP III, LLC - 0.6%
Soleus Capital Master Fund, L.P. - 0.4%
Soleus Capital, LLC - 0.4%
Soleus Capital Group, LLC - 0.4%
Soleus Capital Management, L.P. - 1.0%
Soleus GP, LLC - 1.0%
Guy Levy - 1.0%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
Soleus Private Equity GP III, LLC - 157,400
Soleus Private Equity Fund III, L.P. - 157,400
Soleus PE GP III, LLC - 157,400
Soleus Capital Master Fund, L.P. - 118,912
Soleus Capital, LLC - 118,912
Soleus Capital Group, LLC - 118,912
Soleus Capital Management, L.P. - 276,312
Soleus GP, LLC - 276,312
Guy Levy - 276,312
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
Soleus Private Equity GP III, LLC - 157,400
Soleus Private Equity Fund III, L.P. - 157,400
Soleus PE GP III, LLC - 157,400
Soleus Capital Master Fund, L.P. - 118,912
Soleus Capital, LLC - 118,912
Soleus Capital Group, LLC - 118,912
Soleus Capital Management, L.P. - 276,312
Soleus GP, LLC - 276,312
Guy Levy - 276,312
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Soleus Capital Master Fund, L.P.
Signature:
/s/ Guy Levy
Name/Title:
Guy Levy / Managing Member of the Managing Member of the General Partner of Soleus Capital Master Fund, L.P.
Date:
05/08/2026
Soleus Private Equity Fund III, L.P.
Signature:
/s/ Guy Levy
Name/Title:
Guy Levy / Managing Member of the Sole Manager of the General Partner of Soleus Private Equity Fund III, L.P.
Date:
05/08/2026
Soleus Private Equity GP III, LLC
Signature:
/s/ Guy Levy
Name/Title:
Guy Levy / Managing Member of the Sole Manager of Soleus Private Equity GP III, LLC
Date:
05/08/2026
Soleus PE GP III, LLC
Signature:
/s/ Guy Levy
Name/Title:
Guy Levy / Managing Member
Date:
05/08/2026
Soleus Capital, LLC
Signature:
/s/ Guy Levy
Name/Title:
Guy Levy / Managing Member of the Managing Member of Soleus Capital, LLC
Date:
05/08/2026
Soleus Capital Group, LLC
Signature:
/s/ Guy Levy
Name/Title:
Guy Levy / Managing Member
Date:
05/08/2026
Soleus Capital Management, L.P.
Signature:
/s/ Guy Levy
Name/Title:
Guy Levy / Managing Member of the General Partner of Soleus Capital Management, L.P.
